Showing results (11-20 of 94) with videos related to

Sort By:
Pageof 10
Neurochemistry International|August 7, 2013
(-)-Reboxetine inhibits muscle nicotinic acetylcholine receptors by interacting with luminal and non-luminal sitesHugo R Arias, Marcelo O Ortells, Dominik Feuerbach
Neurochemistry International|September 11, 2016
Bupropion and its photoreactive analog (±)-SADU-3-72 interact with luminal and non-luminal sites at human α4β2 nicotinic acetylcholine receptorsHugo R Arias, Dominik Feuerbach, Marcelo O Ortells
Current Pharmaceutical Design|January 29, 2016
Role of Nicotinic and Muscarinic Receptors on Synaptic Plasticity and Neurological DiseasesMarco Fuenzalida, Miguel Ángel Pérez, Hugo R Arias
Neuroscience Letters|September 3, 2013
Role of the nicotinic receptor β4 subunit in the antidepressant activity of novel N,6-dimethyltricyclo[5.2.1.0²,⁶]decan-2-amine enantiomersKatarzyna M Targowska-Duda, Krzysztof Jozwiak, Hugo R Arias
Neuropharmacology|October 24, 2003
Molecular mechanisms of inhibition of nicotinic acetylcholine receptors by tricyclic antidepressantsFernanda Gumilar, Hugo R Arias, Guillermo Spitzmaul, et al.
Neurochemistry International|December 27, 2017
Coronaridine congeners modulate mitochondrial α3β4* nicotinic acetylcholine receptors with different potency and through distinct intra-mitochondrial pathwaysHugo R Arias, Olena Lykhmus, Kateryna Uspenska, et al.
The International Journal of Biochemistry & Cell Biology|October 19, 2017
Selectivity of coronaridine congeners at nicotinic acetylcholine receptors and inhibitory activity on mouse medial habenulaHugo R Arias, Xiaotao Jin, Dominik Feuerbach, et al.
The International Journal of Biochemistry & Cell Biology|January 19, 2010
Inhibitory mechanisms and binding site location for serotonin selective reuptake inhibitors on nicotinic acetylcholine receptorsHugo R Arias, Dominik Feuerbach, Pankaj Bhumireddy, et al.
The International Journal of Biochemistry & Cell Biology|January 21, 2024
To what extent may aminochrome increase the vulnerability of dopaminergic neurons in the context of Parkinson's diseaseAbdeslam Chagraoui, Youssef Anouar, Philippe De Deurwaerdere, et al.
The International Journal of Biochemistry & Cell Biology|June 7, 2011
Structure-activity relationship of ibogaine analogs interacting with nicotinic acetylcholine receptors in different conformational statesHugo R Arias, Dominik Feuerbach, Katarzyna M Targowska-Duda, et al.
Pageof 10